+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Atopic Dermatitis Market by Treatment Type, Product Type, Distribution Channel, Form Type - Global Forecast to 2030- Product Image
Canine Atopic Dermatitis Market by Treatment Type, Product Type, Distribution Channel, Form Type - Global Forecast to 2030- Product Image
Sale

Canine Atopic Dermatitis Market by Treatment Type, Product Type, Distribution Channel, Form Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337468
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Canine Atopic Dermatitis Market grew from USD 1.69 billion in 2024 to USD 1.84 billion in 2025. It is expected to continue growing at a CAGR of 8.46%, reaching USD 2.76 billion by 2030.

Navigating the Rising Burden of Canine Atopic Dermatitis

Canine atopic dermatitis has emerged as one of the most prevalent chronic inflammatory skin diseases affecting companion animals worldwide. Characterized by intense pruritus, recurrent skin infections and a heightened risk of secondary complications, this condition imposes significant welfare concerns and economic burdens on pet owners and veterinary providers alike. Advances in molecular biology have elucidated key immunological pathways driving the inflammatory cascade, yet translating these findings into accessible, effective therapies remains an ongoing challenge.

The interplay of genetics, environmental allergens and skin barrier disruptions necessitates a multidimensional management framework. As the prevalence of allergic dermatitis continues to climb, stakeholders are compelled to balance clinical efficacy with safety profiles and cost containment. Veterinarians increasingly advocate for preventive care models that integrate early diagnostic screening and owner education to reduce the long‐term treatment burden.

In recent years, market dynamics have shifted in response to evolving scientific insights and changing owner expectations. Growing awareness of the inflammatory nature of atopic dermatitis among pet guardians has fueled demand for targeted interventions that extend beyond symptomatic relief. Stakeholders across the value chain-from biopharmaceutical developers to specialty retailers-are realigning priorities to address the multifactorial needs of affected dogs. This introduction outlines the imperative for a comprehensive understanding of current treatment modalities, regulatory influences and competitive behaviors that are shaping the future of disease management.

Transforming Diagnosis and Care in Canine Atopic Dermatitis

Over the last decade, the landscape of canine atopic dermatitis has been reshaped by breakthroughs in both diagnostic methodologies and therapeutic modalities. High-precision serological assays now enable earlier detection of allergen-specific immunoglobulins, promoting timely intervention and reducing the risk of chronic flare-ups. Concurrently, digital platforms facilitate teleconsultations and remote monitoring, empowering veterinarians to deliver personalized treatment regimens that adapt to disease severity and environmental triggers.

Recent integration of artificial intelligence into diagnostic imaging and environmental risk modeling has further streamlined the identification of allergen exposure patterns, while machine learning algorithms assist in predicting flare frequency and treatment responsiveness. On the therapeutic front, the advent of biologic agents targeting interleukin pathways has forged a new frontier in long-term disease control. Complementary to these innovations, nutraceutical supplements enriched with omega fatty acids and botanical extracts have gained traction among owners seeking holistic alternatives. Traditional systemic therapies, encompassing injections and oral tablets, continue to serve as mainstays for moderate to severe cases, while evolving topical formulations in the form of creams, gels, shampoos and sprays provide critical adjunctive relief. These transformative shifts underscore the importance of an integrated approach that harmonizes cutting-edge science with practical, owner-centric solutions.

Evaluating the 2025 US Tariff Implications on Therapeutic Accessibility

In 2025, the imposition of revised tariff structures on imported veterinary pharmaceuticals will reverberate across the supply chain, influencing pricing and availability of key therapeutic classes. Biologics reliant on complex cold chain logistics face heightened cost pressures, potentially constraining their adoption despite demonstrated efficacy in moderating immunological responses. Similarly, topicals such as creams and gels, shampoos and sprays may encounter elevated import duties, prompting manufacturers to reassess sourcing strategies and local production capabilities in order to mitigate end‐user price escalations.

Prescription medications delivered via injections and oral tablets are not immune to these changes, as tariff realignments could narrow profit margins and slow new product launches. Over‐the‐counter solutions, including supplements formulated to support skin barrier function, might see altered retail pricing dynamics across pharmacies, veterinary clinics and online outlets. Moreover, cross‐border regulatory harmonization efforts and emerging trade agreements could either alleviate or exacerbate these impacts, depending on geopolitical developments. As stakeholders anticipate these regulatory shifts, proactive engagement with policymakers and strategic alliances with domestic manufacturers will be critical to sustaining broad therapeutic access and preserving treatment adherence among canine patients.

Unveiling Market Dynamics Through Treatment and Product Segmentation

Analyzing the market through the prism of treatment type reveals a multifaceted landscape in which biologics, anchored by developments in monoclonal antibodies, represent an innovative frontier aimed at interrupting the underlying immunopathology. Nutraceutical offerings, predominantly formulated as dietary supplements, continue to address milder cases by reinforcing barrier integrity and modulating inflammatory mediators. Systemic therapies administered via injection or in oral tablet form maintain their role as the backbone for moderate to severe disease, offering predictable pharmacokinetics and dose flexibility. Meanwhile, topical solutions encompassing creams and gels, specialized shampoos and targeted sprays remain indispensable for localized symptom management and microbiome restoration.

Product type segmentation distinguishes between over‐the‐counter remedies that emphasize convenience and owner autonomy, and prescription medications governed by stringent regulatory oversight. Distribution channel analysis shows a proliferation of digital storefronts complementing traditional pet specialty outlets, pharmacies and veterinary hospitals and clinics, thereby expanding consumer touchpoints and accelerating product adoption. Form type classification, from creams and gels through to injections, oral tablets, shampoos and sprays, underscores the necessity of tailoring delivery mechanisms to individual canine requirements and owner preferences, ultimately shaping purchasing behavior and treatment adherence.

Regional Variations Driving Differential Growth Trajectories

The Americas continue to dominate market consumption, propelled by a well‐established veterinary infrastructure and high pet health expenditure. In the United States, breakthrough biologics have secured rapid uptake through streamlined approval pathways, while Canada’s focus on preventative healthcare fosters robust growth in nutraceutical supplements and topical maintenance therapies. Transitioning across the Atlantic, Europe operates under a harmonized regulatory framework that balances efficacy verification with rigorous safety standards, resulting in measured yet steady adoption of novel interleukin‐targeted therapies. The Middle East and Africa present a more heterogeneous picture, where varying degrees of veterinary resource availability and import regulations influence access to advanced systemic injections and prescription‐only pharmaceuticals.

Asia‐Pacific markets are characterized by emerging pet ownership trends, with China and India leading in volume growth and an increasing appetite for integrated treatment regimens. Local manufacturers in the region are ramping up production of creams, gels and shampoos to meet price‐sensitive demand, while urban clinics in Australia and Japan emphasize telemedicine support and continuing education for dermatology specialists. Collectively, these regional dynamics illustrate the importance of tailored market entry strategies that reflect local regulatory environments, distribution infrastructures and consumer willingness to invest in canine skin health.

Competitive Landscape Spotlight on Leading Dermatology Innovators

The competitive landscape is marked by a blend of established pharmaceutical giants and nimble biotechs, each vying to deliver the next breakthrough in canine atopic dermatitis care. Incumbent companies leverage expansive R&D budgets to advance monoclonal antibody programs targeting key cytokine pathways, often forging strategic partnerships with contract research organizations to accelerate clinical validation. At the same time, emerging players differentiate through precision nutraceutical formulations, emphasizing proprietary lipid complexes and botanical extracts to address underlying skin barrier deficiencies. Generics manufacturers are also intensifying efforts to introduce cost‐effective versions of established systemic therapies, driving price competition and expanding access across price tiers. Specialized veterinary distributors and online retailers strive to enhance product visibility and service quality through digital engagement platforms and subscription‐based supply models. These varied strategic approaches underscore the imperative for continuous innovation and collaborative ventures that align scientific discovery with market realities.

Strategic Imperatives to Gain Competitive Edge in Canine Atopic Dermatitis Management

Industry leaders must prioritize investment in biologics research to capture the unmet needs of moderate to severe cases while simultaneously reinforcing market presence in cost‐sensitive segments through differentiated nutraceutical offerings. Building resilient supply chains by establishing local manufacturing partnerships will serve to circumvent emerging tariff challenges and maintain consistent product availability. Expanding digital touchpoints via telehealth services and subscription fulfillment platforms can deepen client engagement, bolster adherence and unlock new revenue streams.

Furthermore, leveraging real-world evidence captured through electronic health records and predictive analytics will empower organizations to refine treatment algorithms and personalize pricing models. Forging alliances with veterinary educational bodies and key opinion leaders will accelerate knowledge transfer and drive evidence‐based adoption of advanced therapies. Lastly, integrating real‐world data collection into post‐launch surveillance initiatives will provide actionable insights on long‐term outcomes, enabling continuous optimization of pricing, positioning and portfolio expansion strategies in a dynamically evolving marketplace.

Robust Analytical Framework Underpinning Market Insights

This research employs a rigorous combination of primary and secondary methodologies to ensure the validity and reliability of insights. Primary data collection involved structured interviews with practicing veterinarians across key geographic markets and consultative discussions with industry executives, yielding first‐hand perspectives on therapeutic preferences and adoption barriers. Supplementary surveys of pet owners provided granular data on purchasing patterns, treatment adherence and willingness to invest in preventative regimens. Secondary research incorporated analysis of regulatory filings, scientific literature and proprietary databases to map competitive pipelines and patent landscapes. Advanced quantitative techniques, including trend analysis and segmentation modeling, were applied to synthesize findings across treatment type, product type, distribution channel and form type classifications. This multifaceted approach ensures a comprehensive outlook on current dynamics and future trajectories within the canine atopic dermatitis market.

Converging Trends Point to an Evolving Therapeutic Landscape

In summary, the management of canine atopic dermatitis is rapidly transitioning from symptom‐driven interventions to precision therapies that address immunological underpinnings. Evidence of shifting paradigms is evident across treatment segmentation, distribution channels and geographic regions, with each dimension presenting unique challenges and growth opportunities. The introduction of novel biologics, coupled with consumer demand for holistic nutraceutical solutions, signals a broader industry emphasis on long‐term disease control and quality of life enhancement.

Looking ahead, translational research that bridges human dermatology findings with veterinary applications will play a pivotal role in accelerating next‐generation innovations. Regulatory adaptations, including evolving tariff frameworks, will continue to influence supply chain resilience and market access strategies. Ultimately, organizations that seamlessly integrate scientific innovation with agile market execution, underpinned by robust real‐world evidence, will be best positioned to lead in this dynamic arena, shaping the future of canine skin health and veterinary dermatology.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Treatment Type
    • Biologics
      • Monoclonal Antibodies
    • Nutraceuticals
      • Supplements
    • Systemic Therapies
      • Injections
      • Oral Tablets
    • Topicals
      • Creams & Gels
      • Shampoo
      • Sprays
  • Product Type
    • Otc
    • Prescription
  • Distribution Channel
    • Online Retail
    • Pet Specialty Stores
    • Pharmacies
    • Veterinary Hospitals Clinics
  • Form Type
    • Creams & Gels
    • Injections
    • Oral Tablets
    • Shampoo
    • Sprays
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Merck Sharp & Dohme Corp.
  • Hill's Pet Nutrition, Inc.
  • Virbac S.A.
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals plc
  • Vetoquinol S.A.
  • Royal Canin S.A.S.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Canine Atopic Dermatitis Market, by Treatment Type
8.1. Introduction
8.2. Biologics
8.2.1. Monoclonal Antibodies
8.3. Nutraceuticals
8.3.1. Supplements
8.4. Systemic Therapies
8.4.1. Injections
8.4.2. Oral Tablets
8.5. Topicals
8.5.1. Creams & Gels
8.5.2. Shampoo
8.5.3. Sprays
9. Canine Atopic Dermatitis Market, by Product Type
9.1. Introduction
9.2. Otc
9.3. Prescription
10. Canine Atopic Dermatitis Market, by Distribution Channel
10.1. Introduction
10.2. Online Retail
10.3. Pet Specialty Stores
10.4. Pharmacies
10.5. Veterinary Hospitals Clinics
11. Canine Atopic Dermatitis Market, by Form Type
11.1. Introduction
11.2. Creams & Gels
11.3. Injections
11.4. Oral Tablets
11.5. Shampoo
11.6. Sprays
12. Americas Canine Atopic Dermatitis Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Canine Atopic Dermatitis Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Canine Atopic Dermatitis Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Elanco Animal Health Incorporated
15.3.3. Boehringer Ingelheim International GmbH
15.3.4. Merck Sharp & Dohme Corp.
15.3.5. Hill's Pet Nutrition, Inc.
15.3.6. Virbac S.A.
15.3.7. Ceva Santé Animale S.A.
15.3.8. Dechra Pharmaceuticals plc
15.3.9. Vetoquinol S.A.
15.3.10. Royal Canin S.A.S.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CANINE ATOPIC DERMATITIS MARKET MULTI-CURRENCY
FIGURE 2. CANINE ATOPIC DERMATITIS MARKET MULTI-LANGUAGE
FIGURE 3. CANINE ATOPIC DERMATITIS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CANINE ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CANINE ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CANINE ATOPIC DERMATITIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY CREAMS & GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY SHAMPOO, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY VETERINARY HOSPITALS CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY CREAMS & GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY SHAMPOO, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 56. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 57. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 58. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 59. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CANADA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 103. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 104. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 105. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 106. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 107. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 108. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 111. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 113. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 114. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 115. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 127. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 129. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 130. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 131. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 132. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ITALY CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 135. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 137. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 138. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 139. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 140. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. SPAIN CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 167. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 168. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 169. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 170. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 171. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. DENMARK CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 183. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 185. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 186. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 187. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 188. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. QATAR CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 191. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 193. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 217. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 218. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. EGYPT CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 239. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 241. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 247. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 248. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 249. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 250. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 251. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 252. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. POLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 272. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 273. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 274. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 275. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 276. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 277. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 280. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 282. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 283. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 284. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 285. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 288. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 290. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 291. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY FORM TYPE, 2018-2030 (USD MILLION)
TABLE 320. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 321. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 322. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 323. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY SYSTEMIC THERAPIES, 2018-2030 (USD MILLION)
TABLE 324. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICALS, 2018-2030 (USD MILLION)
TABLE 325. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. THAILAND CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. THAILAND CANINE ATOPIC DERMATITIS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Canine Atopic Dermatitis market report include:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Merck Sharp & Dohme Corp.
  • Hill's Pet Nutrition, Inc.
  • Virbac S.A.
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals plc
  • Vetoquinol S.A.
  • Royal Canin S.A.S.

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.76 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Canine Atopic Dermatitis - Global Strategic Business Report - Product Image

Canine Atopic Dermatitis - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032 - Product Image

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Canine Atopic Dermatitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Canine Atopic Dermatitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Canine Atopic Dermatitis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Canine Atopic Dermatitis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 123 Pages
  • Global
From
Canine Atopic Dermatitis Market 2024-2028 - Product Image

Canine Atopic Dermatitis Market 2024-2028

  • Report
  • 160 Pages
  • Global
From

About the Canine Atopic Dermatitis Market

Canine Atopic Dermatitis (CAD) is a common skin condition in dogs that is caused by an allergic reaction to environmental allergens such as pollen, dust mites, and mold. Symptoms of CAD include itching, redness, and hair loss. Treatment of CAD typically involves the use of anti-inflammatory medications, topical treatments, and allergen-specific immunotherapy. The Animal Healthcare/Veterinary market for CAD is growing as pet owners become more aware of the condition and its treatments. Veterinary clinics are increasingly offering CAD treatments, and the market for CAD treatments is expected to continue to grow. Companies in the Canine Atopic Dermatitis market include Zoetis, Merck Animal Health, Elanco Animal Health, and Bayer Animal Health. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.